These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20465623)

  • 21. Delusional disorder with delusions of parasitosis and jealousy after stroke: treatment with quetiapine and sertraline.
    Blasco-Fontecilla H; Bragado Jiménez MD; García Santos LM; Barjau Romero JM
    J Clin Psychopharmacol; 2005 Dec; 25(6):615-7. PubMed ID: 16282853
    [No Abstract]   [Full Text] [Related]  

  • 22. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delusional parasitosis in leprosy.
    Bhatia MS; Chandra R; Kamra A
    Indian J Lepr; 2002; 74(2):159-60. PubMed ID: 12708735
    [No Abstract]   [Full Text] [Related]  

  • 24. Lactation associated with fluoxetine treatment.
    Arya DK; Taylor WS
    Aust N Z J Psychiatry; 1995 Dec; 29(4):697. PubMed ID: 8825840
    [No Abstract]   [Full Text] [Related]  

  • 25. Delusional infestation: clinical presentation in 147 patients seen at Mayo Clinic.
    Foster AA; Hylwa SA; Bury JE; Davis MD; Pittelkow MR; Bostwick JM
    J Am Acad Dermatol; 2012 Oct; 67(4):673.e1-10. PubMed ID: 22264448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pimozide at least as safe and perhaps more effective than olanzapine for treatment of Morgellons disease.
    Koblenzer CS
    Arch Dermatol; 2006 Oct; 142(10):1364. PubMed ID: 17043201
    [No Abstract]   [Full Text] [Related]  

  • 27. Delusions of parasitosis.
    Lee CS
    Dermatol Ther; 2008; 21(1):2-7. PubMed ID: 18318879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delusional parasitosis: a practical guide for the family practitioner in evaluation and treatment strategies.
    Winsten M
    J Am Osteopath Assoc; 1997 Feb; 97(2):95-9. PubMed ID: 9059004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delusional parasitosis: case series of 8 patients and review of the literature.
    Aw DC; Thong JY; Chan HL
    Ann Acad Med Singap; 2004 Jan; 33(1):89-94. PubMed ID: 15008571
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder: a retrospective case series and review of the literature.
    Mews MR; Quante A
    J Clin Psychopharmacol; 2013 Aug; 33(4):512-9. PubMed ID: 23771191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride].
    Wolf K; Veismann S; Knecht G; Naber D
    Psychiatr Prax; 2006 Jan; 33(1):42-4. PubMed ID: 16389582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of chronic delusional parasitosis.
    Mitchell C
    Br J Psychiatry; 1989 Oct; 155():556-7. PubMed ID: 2611580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A descriptive retrospective study of the treatment and outpatient service use in a clinical group of delusional disorder patients.
    González-Rodríguez A; Molina-Andreu O; Imaz Gurrutxaga ML; Catalán Campos R; Arroyo MB
    Rev Psiquiatr Salud Ment; 2014; 7(2):64-71. PubMed ID: 23490496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topiramate-induced delusional parasitosis.
    Fleury V; Wayte J; Kiley M
    J Clin Neurosci; 2008 May; 15(5):597-9. PubMed ID: 18313929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
    Alptekin K; Hafez J; Brook S; Akkaya C; Tzebelikos E; Ucok A; El Tallawy H; Danaci AE; Lowe W; Karayal ON
    Int Clin Psychopharmacol; 2009 Sep; 24(5):229-38. PubMed ID: 19531959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of delusional parasitosis in severe heart failure. Olanzapine within the framework of a multimodal therapy].
    Freudenmann RW
    Nervenarzt; 2003 Jul; 74(7):591-5. PubMed ID: 12861369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects.
    Amann BL; Pogarell O; Mergl R; Juckel G; Grunze H; Mulert C; Hegerl U
    Hum Psychopharmacol; 2003 Dec; 18(8):641-6. PubMed ID: 14696024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delusional parasitosis over dermatological morbidity: diagnostic and therapeutic challenges.
    Suganthan JS; Rajkumar AP; Jagannath C; Pulimood SA; Jacob KS
    Trop Doct; 2009 Jan; 39(1):49-50. PubMed ID: 19211429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tourette syndrome: a follow-up study.
    Sandor P; Musisi S; Moldofsky H; Lang A
    J Clin Psychopharmacol; 1990 Jun; 10(3):197-9. PubMed ID: 2115892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.